Clinical Trials Browser

empagliflozin × Breast × 30 days × Clear all

NCT06844669 2026-05-13

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Phase 2 Terminated

Breast Neoplasms, Heart Failure, Cardiotoxicity